GoodRx Holdings, Inc. GDRX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s EPS (diluted)?
- GoodRx Holdings, Inc. (GDRX) reported EPS (diluted) of $0.00 in Q1 2026.
- How has GoodRx Holdings, Inc.'s EPS (diluted) changed year-over-year?
- GoodRx Holdings, Inc.'s EPS (diluted) decreased by 100.0% year-over-year, from $0.03 to $0.00.
- What is the long-term trend for GoodRx Holdings, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s EPS (diluted) has grown at a 10.7% compound annual growth rate (CAGR), from -$0.06 to $0.09.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.